Nexentis Technologies Inc.
Pharmaceutical Preparations · New York, NY, United States
- PrincipalsDavid PalachChief Executive OfficerLital BardaChief Financial Officerand 2 more
- CompanyNexentis Technologies Inc.New York, NY, United States
Nexentis Technologies Inc. is an SEC-registered Nasdaq-listed company (ticker NXTS) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 4
Chief executive
David PalachChief Executive Officer
Chair & board
Amitay WeissDirector (Board)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗David Palach — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Lital Barda — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Shlomo Zakai — Controller
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Amitay Weiss — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Xenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capability